Immunic AG Logo

Immunic AG

IMUX | NDAQ

Overview

Corporate Details

ISIN(s):
US4525EP1011
LEI:
549300R5T12FW5MEQB20
Country:
United States of America
Address:
C/O The Corporation Trust Company, 19801 Wilmington
Sector:
Health Care
Industry:
Biotechnology

Description

No description available.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-24 12:30
Regulatory News Service
Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 …
English 15.2 KB
2025-06-05 12:30
Earnings Release
Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Re…
English 18.3 KB
2025-06-02 12:30
Regulatory News Service
Immunic to Participate in Investor, Scientific and Industry Conferences in June
English 13.9 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
CHOSA Oncology AB Logo CHOSA Oncology AB Sweden CHOSA
Cinclus Pharma Holding AB Logo Cinclus Pharma Holding AB Sweden CINPHA
Circio Holding ASA Logo Circio Holding ASA Norway CRNA
CIZZLE BIOTECHNOLOGY HOLDINGS PLC Logo CIZZLE BIOTECHNOLOGY HOLDINGS PLC United Kingdom CIZ
CLAL Biotechnology Industries Ltd. Logo CLAL Biotechnology Industries Ltd. Israel CBI
Combigene AB Logo Combigene AB Sweden COMBI
Compugen Ltd. Logo Compugen Ltd. Israel CGEN
Corline Biomedical AB Logo Corline Biomedical AB Sweden CLBIO
CRISM Therapeutics Corporation Virgin Islands (British) N/A
Curasight A/S Logo Curasight A/S Denmark CURAS